Human p35 tagged with a histidine hexamer at the C terminus was purified from Sf9 insect cells as described previously (Sakaue et al., 2005; Yamada et al., 2007) . 3 µg of the recombiant p35 protein was incubated with or without recombinant human PKC (10 ng, 0.0533 Unit) in a buffer consisting of 50 mM Tris-HCl (pH 7.5), 0.1% 2-mercaptoethanol, 0.1 mM EGTA, 0.1 mM sodium vanadate, 10 mM magnesium acetate, 100 µM [ -32 HEK 293 cells were transfected with constitutively active PKC together with either WT or S33A-mutated p35. 24 hours after transfection cells were incubated in phosphate-free minimum essential medium Eagle (MEME, Sigma) supplemented with 10% FBS, 2 mM L-glutamine and antibiotics for 30 minutes followed by labelling with 0.3 mCi/ml 32 P-orthophosphate (PerkinElmer) in minimum essential medium for 3 hours. Cells were harvested, rinsed with PBS and subjected to p35
immunoprecipitation. for 30 min followed by centrifugation at 15000 x g for 10 min at 4°C. Lysates were precleared using 50% slurry of protein A-Sepharose beads (Sigma-Aldrich, St Louis, MO, USA) for 1 h at 4°C and the cleared cell lysates were immunoprecipitated with anti-p35 antibody (C-19; Santa Cruz Biotechnology Inc) over night at 4°C.
Immunocomplexes were captured with protein A-Sepharose beads for 4 h at 4°C, washed three times with immunoprecipitation buffer and resuspended in Laemmli sample buffer. The resulting immunoprecipitates were resolved by 12.5% SDS-PAGE gel followed by autoradiography analysis with an imaging screen using Fujifilm BAS-1800 Bioimaging analyzer (A).
In-gel tryptic digestions of 32 P-labeled WT and S33A-mutated p35 followed by a twodimensional phosphopeptide mapping (2-D-PPM) were carried out as previously described (Kochin, et al., 2006) . Briefly, the labeled p35 band was excised from the dried gel and in-gel digested with sequencing grade trypsin (Promega). The gel pieces were incubated with 2 ng/ L trypsin in 50 mM ammonium bicarbonate buffer (pH 8)
for 16 h at 37°C. Supernatants were collected, vacuum-dried and resuspended in 15 µL of pH 1.9 buffer (formic acid 2.3%, acetic acid 2.9% v/v).
Peptides were then separated in two dimensions by electrophoresis and thin layer chromatography (TLC). The first dimension -electrophoresis -was performed in a pH 1.9 buffer at 750 V for 1.5 h using the Hunter Thin Layer Peptide Mapping System, model # HTLE-7000 (C.B.S. Scientific). 15 µL of the tryptic digest together with the 3 µL of separation markers mixture (Xylene Cyanol FF (blue), 1 mg/ml and N -DNP-Llysine hydrochloride (yellow), 5 mg/ml, Sigma) were carefully applied on a cellulose sheet (20 cm x 20 cm, Merck KgaA) and electrophoretically separated. The sheet was dried and ascending TLC in the second dimension was performed for 13 h in a chromatography tank saturated with a mobile phase containing 30% water, 37.5% nbutanol, 7.5% acetic acid, and 25% pyridine. The sheet was dried and the 32 -phosphopeptides were visualized by autoradiography (B).
Suppl. Fig.6 . A stable Cdk5 activator, p25, is generated in a calpaindependent manner during myoblast differentiation.
(A) p35 is cleaved to p25 fragment during the differentiation of myoblasts.
Primary myoblasts were induced to differentiate and lysates harvested at indicated time points were resolved on a gel and blotted against p35. 
